Niraparib 200/300 MG Clinical Trials
2 recruitingDrug
Phase 21
Showing 1–2 of 2 trials
Recruiting
Phase 2
PLATFORM Study of Precision Medicine for Rare Tumors
Rare Tumor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences770 enrolled1 locationNCT04423185
Recruiting
Niraparib Maintenance Treatment in Patients With Newly Diagnosed Advanced Platinum- Sensitive, OC. The First Poland RWE Study.
Ovarian Cancer
Pomeranian Medical University Szczecin300 enrolled12 locationsNCT06614790